dihydroergotamine has been researched along with fibrinogen in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buttermann, G; Hör, G; Pabst, HW; Theisinger, W | 1 |
| Fey, KH; Herzfeld, U; Oehlschläger, M; Saggau, W | 1 |
| Buttermann, G; Hör, G; Oechsler, H; Theisinger, W | 1 |
| Gaudernak, T; Kuderna, H; Pelinka, H; Schlag, G; Welzel, D | 1 |
| Alfaro, MJ; Páramo, JA; Rocha, E | 1 |
| Astedt, B; Bernstein, K; Kullander, S; Svanberg, L | 1 |
| Astedt, B; Bernstein, K; Jacobsson, L; Mattsson, S; Ulmsten, U | 1 |
| Brauckhoff, KF; Heerdegen, R; Liedloff, H | 1 |
| Neumann, K; Schemper, M; Zekert, F | 1 |
| Ofoegbu, RO; Osime, U | 1 |
| Donath, A; Krähenbühl, B; Moser, G | 1 |
6 trial(s) available for dihydroergotamine and fibrinogen
| Article | Year |
|---|---|
Prevention of postoperative thromboembolism by various treatments. Controlled clinical trial in 632 patients using 125I-fibrinogen uptake test and lung perfusion scans in patients with deep venous thrombosis.
Topics: Clinical Trials as Topic; Dihydroergotamine; Drug Therapy, Combination; Fibrinogen; Heparin; Humans; Iodine Radioisotopes; Postoperative Complications; Pulmonary Embolism; Radionuclide Imaging; Thromboembolism | 1976 |
[Postoperative prevention of thrombosis through the tonicizing of the caudal venous system. A new principle of drug therapy].
Topics: Blood Circulation; Catecholamines; Dihydroergotamine; Ergotamines; Exercise Therapy; Female; Fibrinogen; Hemostasis; Humans; Iodine Radioisotopes; Leg; Male; Middle Aged; Muscle Tonus; Norepinephrine; Postoperative Care; Postoperative Complications; Stimulation, Chemical; Thromboembolism; Thrombophlebitis; Veins | 1975 |
[Prevention of postoperative thrombo-embolism using a new principle of drug treatment (author's transl)].
Topics: Adult; Analysis of Variance; Blood Flow Velocity; Dihydroergotamine; Endothelium; Female; Fibrinogen; Humans; Iodine Radioisotopes; Male; Middle Aged; Postoperative Complications; Thromboembolism; Time Factors; Veins | 1975 |
Thromboembolic prophylaxis in hip fracture.
Topics: Acenocoumarol; Aged; Aged, 80 and over; Bone Nails; Dihydroergotamine; Drug Evaluation; Drug Therapy, Combination; Female; Fibrinogen; Heparin; Hip Fractures; Humans; Iodine Radioisotopes; Iothalamate Meglumine; Middle Aged; Radiography; Radionuclide Imaging; Random Allocation; Thromboembolism; Time Factors | 1986 |
Acetylsalicylic acid in combination with dihydroergotamine for preventing thromboembolism.
Topics: Adult; Aged; Aspirin; Dihydroergotamine; Drug Therapy, Combination; Female; Fibrinogen; Humans; Male; Middle Aged; Pulmonary Embolism; Thromboembolism | 1982 |
[Prevention of deep venous thrombosis (TVP) and pulmonary embolism. Comparison of heparin (3 x 5000 IU/day), heparin (2 x 5000 IU/day) + 0.5 mg dihydroergot, and physiotherapy (intermittent compression stockings + physical exercise). Value of Doppler diag
Topics: Adult; Aged; Clothing; Dihydroergotamine; Drug Administration Schedule; Drug Therapy, Combination; Exercise Therapy; Female; Fibrinogen; Heparin; Humans; Leg; Male; Middle Aged; Phlebography; Physical Therapy Modalities; Postoperative Complications; Pulmonary Embolism; Radionuclide Imaging; Random Allocation; Thrombophlebitis; Ultrasonography | 1980 |
5 other study(ies) available for dihydroergotamine and fibrinogen
| Article | Year |
|---|---|
Postoperative changes in the plasmatic levels of tissue-type plasminogen activator and its fast-acting inhibitor--relationship to deep vein thrombosis and influence of prophylaxis.
Topics: alpha-2-Antiplasmin; Aspirin; Dihydroergotamine; Drug Therapy, Combination; Fibrinogen; Glycoproteins; Heparin; Hip Prosthesis; Humans; Plasminogen Activators; Plasminogen Inactivators; Postoperative Complications; Thrombophlebitis; Tissue Plasminogen Activator | 1985 |
Effect of dihydroergotamine on coagulation factors and components of the fibrinolytic system.
Topics: Aged; alpha-Macroglobulins; Antithrombin III; Blood Coagulation Factors; Dihydroergotamine; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Middle Aged; Plasminogen; Thrombophlebitis | 1980 |
Incidence of thrombosis after gynecologic surgery evaluated by an improved 125I-fibrinogen uptake test.
Topics: Age Factors; Dextrans; Dihydroergotamine; Female; Fibrinogen; Humans; Hysterectomy; Iodine Radioisotopes; Middle Aged; Postoperative Complications; Thrombophlebitis; Uterine Prolapse | 1980 |
[Hematoma and thrombosis prevention after hip surgery].
Topics: Dihydroergotamine; Female; Fibrinogen; Hematoma; Heparin; Hip Prosthesis; Humans; Iodine Radioisotopes; Male; Middle Aged; Thrombosis; Time Factors | 1984 |
Prevention and treatment of early postoperative deep vein thrombosis in africans: a Nigerian experience with dihydroergotamine mesylate.
Topics: Adult; Aged; Dihydroergotamine; Female; Fibrinogen; Humans; Male; Middle Aged; Nigeria; Postoperative Complications; Prostatectomy; Thoracic Surgery; Thrombophlebitis; Time Factors; Vagotomy | 1981 |